Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-29

Clinical Trial Update: The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia [NA]

View source ↗

Summary

Clinical trial update on the effect of 0.5% roxithromycin lotion for androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roxithromycin lotion (roxithromycin)

Snippet

Sponsor: Hamamatsu University | Conditions: Alopecia | NA | Status: UNKNOWN